Our vision is to use genomic tools

• To describe the transmission of infectious disease in order to inform infectious outbreak control policy
• To provide an immediate view of the evolution of resistance to host immunity and drug pressure

We are well placed to deliver insights in this area given the availability of samples over 25 years of continuous sampling with detailed clinical and spatial data; international partners providing availability to geographically diverse samples; bioinformatics and sequencing technology within Kilifi; and established collaborations with the Wellcome Trust Sanger Institute to enable high-throughput sequencing.